Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $37,544
46%  
Woo hoo!! And we're now over 46%!! Thank you all very much!! God bless.

Keyword: bloodcancer

Brevity: Headers | « Text »
  • House Majority Leader Steve Scalise Reveals Cancer Diagnosis

    08/29/2023 11:06:52 AM PDT · by SeekAndFind · 8 replies
    Townhall ^ | 08/29/2023 | Spencer Brown
    House Majority Leader Steve Scalise (R-LA) revealed on Tuesday morning that he was recently diagnosed with Multiple Myeloma, what he calls "a very treatable blood cancer." "After a few days of not feeling like myself this past week, I had some blood work done," Scalise posted on X (formerly Twitter) on Tuesday morning. "The results uncovered some irregularities and after undergoing additional tests, I was diagnosed with Multiple Myeloma, a very treatable blood cancer." Scalise says he has "now begun treatment, which will continue for the next several months." While undergoing treatment, he said that he expects to continue working...
  • Steve Scalise

    08/29/2023 8:23:53 AM PDT · by Kevin in California · 12 replies
    08/29/2023
    Bannon just said there was breaking news on Scalise's health and that whatever the issue, it was critical and he Bannon) was sending his prayers. I cannot find anything in the news regarding this so if someone has news, please share.
  • 90% of patients respond to new blood cancer treatment in trial...The therapy uses souped-up immune cells to fight multiple myeloma.

    06/13/2023 9:44:52 AM PDT · by Red Badger · 5 replies
    FreeThink ^ | June 12, 2023 | By B. David Zarley
    Anew cancer therapy developed at Jerusalem’s Hadassah-University Medical Center had a 90% response rate in a new clinical trial, with over half of patients going into total remission. The CAR-T therapy — which arms the body’s own immune cells to fight cancer — was able to send multiple myeloma, an extremely deadly cancer that impacts the immune system, into remission. The therapy is the result of years worth of experiments conducted by the hospital’s bone-marrow transplant and immunotherapy department, the Jerusalem Post reported. “We have evidence of a very positive overall response rate with minimal side effects, and they are...
  • Treatment found to reduce progression of rare blood cancer by 74% (Carvykti helps multiple myeloma )

    06/07/2023 11:05:52 AM PDT · by ConservativeMind · 3 replies
    A treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type of blood cancer, results showed. Ciltacabtagene autoleucel—also known by Carvykti—was tested in a clinical trial involving 419 patients with multiple myeloma, whose disease was not responsive to the current frontline drug lenalidomide, a chemotherapy medicine. Multiple myeloma affects a type of white blood cells called plasma cells, and can cause cascading harms to the bones, kidneys, and immune health. There is currently no cure, though progression can be stopped for...
  • Whoopi Goldberg: Colin Powell May Not Have Died as Quickly ‘Had Everybody Been Vaccinated’

    10/19/2021 1:12:29 PM PDT · by ChicagoConservative27 · 139 replies
    Breitbart ^ | 10/19/2021 | Pam Key
    Whoopi Goldberg told her co-hosts Tuesday on ABC’s “The View” that former Secretary of State Colin Powell may not have died if more Americas were vaccinated against COVID-19. Goldberg said, “Here’s my thing, at some point, people are going to have to grow up. You’re either going to have to make a decision. Five gazillion of us are vaccinated, and we’re okay. Yeah, people have died. People have died having been vaccinated. As of October, there have been 7,178 fatal breakthrough cases that have been reported to the CDC.”
  • Discovery suggests potential new treatment for deadly blood cancer

    08/11/2021 10:55:54 AM PDT · by Red Badger
    https://medicalxpress.com ^ | 11 AUGUST 2021 | by Josh Barney, University of Virginia
    A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis, new research from UVA Cancer Center suggests. The drug, palbociclib, may be able to prevent the scarring of bone marrow that existing treatments for myelofibrosis cannot. This scarring disrupts the marrow's production of blood cells and causes severe anemia that leaves patients weak and fatigued. The scarring also reduces the number of platelets in the blood, making clotting difficult, and often causes an enlarged spleen. "Current therapies only provide symptomatic relief without offering significant improvement of bone...
  • Woman, 67, who battled blood cancer for five years 'recovers after treating it with TURMERIC'

    01/03/2018 6:56:28 AM PST · by Red Badger · 47 replies
    www.dailymail.co.uk ^ | Updated: 04:33 EST, 3 January 2018 | By Ben Spencer, Medical Correspondent
    A woman who battled blood cancer for years without success finally halted the disease with turmeric, it has been reported. Dieneke Ferguson is now leading a normal life after giving up on gruelling treatments that failed to stop it. Doctors say her case is the first recorded instance in which a patient has recovered by using the spice after stopping conventional medical treatments. With her myeloma spreading rapidly after three rounds of chemotherapy and four stem cell transplants, the 67-year-old began taking 8g of curcumin a day – one of the main compounds in turmeric. The cancer, which has an...
  • Adult Stem Cell Research Shows Good Long-Term Results, Study Says

    09/21/2005 10:07:34 AM PDT · by Coleus · 12 replies · 410+ views
    Life News ^ | 09.19.05 | Steven Ertelt
    Adult Stem Cell Research Shows Good Long-Term Results, Study Saysby Steven ErteltLifeNews.com Editor September 19, 2005Seattle, WA (LifeNews.com) -- Clinical trials of treatments of patients using adult stem cells shows positive results, but doctors have not known whether patients will continue showing progress long-term. A new study of blood cancer patients who had stem cell transplants are nearly as healthy as their peers 10 years later.Researchers at Fred Hutchinson Research Cancer Center examined 137 patients a decade after their procedures.Reporting their results in the Journal of Clinical Oncology, the researchers say they were "largely indistinguishable" from the general population.The finding...